Frederic H. Moll, Director at Shockwave Medical, Inc. (SWAV), sold 111,250 shares at $258.95 ($28.6M) on 2024-02-21, disclosed to the SEC on 2024-02-22.
Open-market sale of $28.6M SWAV by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $255.14 | 6,444 | $1.6M | 5.7% |
| 2 | $255.14 | 6,444 | $1.6M | 5.7% |
| 3 | $255.95 | 16,464 | $4.2M | 14.7% |
| 4 | $255.95 | 16,464 | $4.2M | 14.7% |
| 5 | $256.82 | 14,165 | $3.6M | 12.7% |
| 6 | $256.82 | 14,165 |
| $3.6M |
| 12.7% |
| 7 | $258.09 | 8,649 | $2.2M | 7.8% |
| 8 | $258.09 | 8,649 | $2.2M | 7.8% |
| 9 | $258.95 | 2,660 | $689K | 2.4% |
| 10 | $259.91 | 5,528 | $1.4M | 5.0% |
| 11 | $259.91 | 5,528 | $1.4M | 5.0% |
| 12 | $260.80 | 4,890 | $1.3M | 4.5% |
| 13 | $261.96 | 1,200 | $314K | 1.1% |
| Total | $257.15 avg | 111,250 | $28.6M | 100% |
| Filing → |
| SSII | BUY | 2025-02-24 | $10.0M | — | Filing → |
| SSII | BUY | 2025-01-10 | $4.0M | — | Filing → |
| SSII | BUY | 2025-01-03 | $6.0M | — | Filing → |